IAP Drug Formulary - HOME

Web Update 2023 (4) Edition 70 ready for sync
This IAP DF Web Update 2023 (4), which is ready for download, is the 70th Web Edition and the 68th Web Update of the IAP Drug Formulary. This edition contains addition of a new disease recommendation. The Android app has been further optimised and a new update is available on the Play store. The App is also available on the iOS App store. We also have a brand new website as part of the IAPDF 2.0 launch. Please read the release notes for more information.

On the mobile apps, IAP Essential Medicines List and General Prescribing Information links have been added. The user interface of the mobile apps has been improved to make it more user friendly. It is available for iOS (iPhone, iPad), Android, Symbian and Blackberry and will soon be available on the Windows app platform.
From the Editor's Desk

Dr. Jeeson C Unni

This IAP DF Web Update 2023 (4), which is ready for download, is the 70th Web Edition and the 68th Web Update of the IAP Drug Formulary. This edition contains addition of a new disease recommendation. The Android app has been further optimised and a new update is available on the Playstore. The App is also available on the iOS App store. Please read the release notes for more information.

The IAP Drug Formulary (IAP DF), first published in 2004-2005, has completed 14 yrs of service to the pediatric specialists in our country and abroad, being the only exclusively pediatric formulary in the world, other than the British National Formulary for Children (BNFc). 

IAP President's Message

Dr. Upendra Kinjawadekar 

(IAP President 2023)

Dear friends,

The post covid era is still throwing multiple challenges at the current age pediatrician while making a diagnosis and treating the unusual presentations of some old infections. The current adenoviral infection wave running across the country and the discussions on various academic forums about the use of cidofovir which most of us have never used before or IVIG has reconfirmed the fact that we need to be updated about use of various drugs in day-to-day practice.